<DOC>
	<DOCNO>NCT02232698</DOCNO>
	<brief_summary>The purpose study evaluate impact Abbott Sensor Based Glucose Monitoring System hypoglycaemia compare Self Monitoring Blood Glucose ( SMBG ) test use randomise control study design adult Type 1 diabetes use insulin .</brief_summary>
	<brief_title>An Evaluation Novel Glucose Sensing Technology Hypoglycaemia Type 1 Diabetes ( IMPACT )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Hypoglycemia</mesh_term>
	<criteria>1 . Diagnosed Type 1 diabetes ≥ 5 year 2 . On current insulin regimen ≥ 3 month prior study entry 3 . Screening HbA1c result ≤ 7.5 % ( 58 mmol/mol ) 4 . Reports self test blood glucose level regular basis equivalent minimum 3 time daily least 2 month prior study entry 5 . In investigator 's opinion subject consider technically capable use Abbott Sensor Based Glucose Monitoring System 6 . Aged 18 year . 1 . Subject diagnosed hypoglycaemic unawareness ( i.e . subject diagnosis impair awareness hypoglycaemia record medical note OR investigator 's opinion subject currently experience less minimal warning symptom impend hypoglycaemia ) 2 . Subject currently prescribe animal insulin 3 . Subject currently prescribe oral steroid therapy likely require oral steroid therapy acute chronic condition study 4 . Has know allergy medical grade adhesives 5 . Currently participate another device drug study could affect glucose measurement glucose management 6 . Currently use Continuous Glucose Monitoring ( CGM ) device use one within previous 4 month 7 . Currently use Sensor augment pump therapy 8 . Is plan use CGM device time study 9 . A female subject pregnant planning become pregnant within study duration 10 . A breast feeding mother 11 . Currently receive dialysis treatment plan receive dialysis study 12 . Has pacemaker 13 . Has experience acute myocardial infarction within previous 6 month 14 . Has concomitant disease condition may compromise subject safety include ; unstable coronary heart disease , cystic fibrosis , serious psychiatric disorder , uncontrolled medical condition 15 . Has experience episode confirm suspect diabetic ketoacidosis ( DKA ) previous 6 month 16 . In investigator 's opinion , subject consider unsuitable inclusion study reason .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Sensing Technology</keyword>
	<keyword>Type 1 Diabetes ,</keyword>
</DOC>